2020 annual financial data

Alnylam Pharmaceuticals 2020 Net margin

Direct answer

Net margin was -174.15%.

Operating income was -828.44M USD and net income was -858.28M USD.
Operating cash flow was -614.96M USD.

Get free Alnylam Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
492.85M USD
Operating income
-828.44M USD
Net income
-858.28M USD
Operating cash flow
-614.96M USD